Endocrinology, Vol 124, 3131-3133, Copyright © 1989 by Endocrine Society

ARTICLES

Tumor necrosis factor-alpha is a potent ACTH secretagogue: comparison to interleukin-1 beta

BM Sharp, SG Matta, PK Peterson, R Newton, C Chao and K Mcallen
Endocrine-Neuroscience Research Lab, Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota.

Tumor necrosis factor-alpha (TNF) and interleukin-1 beta (IL-1) are secreted by activated monocytes and other immune cells. Since IL-1 has been shown to elevate rat plasma ACTH and both of these cytokines induce similar acute-phase responses, the present studies of TNF were undertaken to characterize the ACTH response to this immune cell product. Human rTNF, administered iv at doses (100-1000 ng) which failed to affect blood pressure, food consumption or prolactin levels, resulted in significant peak elevations of rat plasma ACTH within 20 min (mean +/- SE 304 +/- 94 and 958 +/- 128 pg/ml for 100 and 1000 ng, respectively, compared to 53 +/- 16 pg/ml for vehicle). rTNF from two different sources produced similar elevations of ACTH as an equivalent amount of rIL-1. TNF failed to affect cultured anterior pituicytes, and it did not modify the response to CRF. When administered into the upper third cerebroventricle, TNF 20 ng failed to affect ACTH levels whereas IL-1 30 ng raised ACTH to 638 +/- 79 pg/ml compared to 177 +/- 24 pg/ml for vehicle (p less than .001). Furthermore, intraparenchymal injection of IL-1, directly above the median eminence, elevated ACTH to 484 +/- 93 pg/ml; again, TNF was completely ineffective. Thus, TNF-alpha and IL- 1 beta are both potent ACTH secretagogues with complementary modes of action; however, the proximate target of TNF action appears to be peripheral to the CNS and pituitary whereas that of IL-1 appears to be the median eminence.

This article has been cited by other articles:

				I. V. Mikhaylova, T. Kuulasmaa, J. Jaaskelainen, and R. Voutilainen Tumor Necrosis Factor-{alpha} Regulates Steroidogenesis, Apoptosis, and Cell Viability in the Human Adrenocortical Cell Line NCI-H295R Endocrinology, January 1, 2007; 148(1): 386 - 392. [Abstract] [Full Text] [PDF]

				S. K. Andersen, J. Gjedsted, C. Christiansen, and E. Tonnesen The roles of insulin and hyperglycemia in sepsis pathogenesis J. Leukoc. Biol., March 1, 2004; 75(3): 413 - 421. [Abstract] [Full Text] [PDF]

				A. Beishuizen and L. G. Thijs Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis Innate Immunity, February 1, 2003; 9(1): 3 - 24. [Abstract] [PDF]

				A. J. DUNN Cytokine Activation of the HPA Axis Ann. N.Y. Acad. Sci., January 1, 2000; 917(1): 608 - 617. [Abstract] [Full Text] [PDF]

				S. Rivest, S. Lacroix, L. Vallières, S. Nadeau, J. Zhang, and N. Laflamme How the Blood Talks to the Brain Parenchyma and the Paraventricular Nucleus of the Hypothalamus During Systemic Inflammatory and Infectious Stimuli Experimental Biology and Medicine, January 1, 2000; 223(1): 22 - 38. [Abstract] [Full Text]

				N. Takahashi, W. Waelput, and Y. Guisez Leptin Is an Endogenous Protective Protein against the Toxicity Exerted by Tumor Necrosis Factor J. Exp. Med., January 4, 1999; 189(1): 207 - 212. [Abstract] [Full Text] [PDF]

				Y. Ohno, M. Fujimoto, A. Nishimura, and N. Aoki Change of Peripheral Levels of Pituitary Hormones and Cytokines after Injection of Interferon (IFN)-{beta} in Patients with Chronic Hepatitis C J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3681 - 3687. [Abstract] [Full Text]

				M. Katahira, Y. Iwasaki, Y. Aoki, Y. Oiso, and H. Saito Cytokine Regulation of the Rat Proopiomelanocortin Gene Expression in AtT-20 Cells Endocrinology, May 1, 1998; 139(5): 2414 - 2422. [Abstract] [Full Text] [PDF]

				A. Creange, L. Belec, B. Clair, J.-D. Degos, J.-C. Raphael, and R. K Gherardi Circulating transforming growth factor beta 1 (TGF-beta 1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function J. Neurol. Neurosurg. Psychiatry, February 1, 1998; 64(2): 162 - 165. [Abstract] [Full Text] [PDF]

				A. V. Turnbull, F. J. Pitossi, J.-J. Lebrun, S. Lee, J. C. Meltzer, D. M. Nance, A. del Rey, H. O. Besedovsky, and C. Rivier Inhibition of Tumor Necrosis Factor-alpha Action within the CNS Markedly Reduces the Plasma Adrenocorticotropin Response to Peripheral Local Inflammation in Rats J. Neurosci., May 1, 1997; 17(9): 3262 - 3273. [Abstract] [Full Text] [PDF]